Pekka Vallittu | Biomaterials | Distinguished Scientist Award

Prof. Pekka Vallittu | Biomaterials | Distinguished Scientist Award 

Professor, at Institute of Dentistry, Finland.

Professor Pekka K. Vallittu, born in 1965 in Mikkeli, Finland, is a distinguished figure in the field of biomaterials science. He holds degrees in Dental Technology (1988), Doctor of Dental Surgery, and Doctor of Philosophy (1994). Specializing in prosthodontics and stomatognathic physiology, Vallittu became a European Prosthodontic Association Recognized Prosthodontist in 2000. Currently, he serves as a Full Professor and Chair of Biomaterials Science at the University of Turku. His career spans various academic and clinical roles, including Head of the Institute of Dentistry at the University of Turku and Director of the Turku Clinical Biomaterials Centre. Vallittu has been instrumental in establishing several companies, such as Skulle Implants Corporation and Stick Tech Ltd, focusing on innovative dental and medical biomaterials. His research has significantly impacted clinical practices worldwide. theshift.fi+1utu.fi+1theshift.fi+2utu.fi+2utu.fi+2utu.fi+2utu.fi+2theshift.fi+2

Professional Profile

Scopus

ORCID

🎓 Education

Professor Vallittu’s academic journey commenced with a Certified Dental Technician qualification in 1988. He then pursued higher education at the University of Kuopio, earning his Licentiate of Odontology (DDS) in 1994, followed by a Doctor of Odontology (PhD) in the same year. In 2000, he achieved the status of EPA-Recognized Specialist in Prosthodontics, specializing in Prosthetic Dentistry and Stomatognathic Physiology. His educational path reflects a deep commitment to advancing dental sciences, laying a robust foundation for his subsequent research and clinical contributions.

💼 Experience

Professor Vallittu’s professional experience is extensive and multifaceted. Since 2006, he has been a Full Professor and Chair of Biomaterials Science at the University of Turku. His leadership roles include serving as Head of the Institute of Dentistry at the University of Turku from 2004 to 2012 and as Director of the Turku Clinical Biomaterials Centre since 2008. Additionally, Vallittu has held positions such as Chief Dentist (part-time) at the VARHA Welfare District of South-West Finland and Honorary Professor at the University of Hong Kong. His involvement in various academic and clinical settings underscores his dedication to integrating research with practical applications in dentistry. utu.fi

🔬 Research Interests

Professor Vallittu’s research interests encompass a broad spectrum within biomaterials science. He has pioneered studies on fiber-reinforced composites (FRCs), bioactive glasses, and bioceramics, focusing on their applications in dental and medical fields. His recent work delves into natural-based fibers, cellulose nanocrystals, biomineralization processes, and hydrogels, aiming to develop sustainable and biocompatible materials. Collaborating with experts across various disciplines, Vallittu strives to translate his research findings into clinical innovations, addressing challenges in bone regeneration and dental restorations. utu.fi

🏆 Awards

Professor Vallittu’s exceptional contributions have been recognized through numerous prestigious awards. In 2025, he was honored as an Invited Corresponding Member of the Odontologiska Samfundet I Finland and received the Apollonia Finnish Dental Society Silver Decoration. The previous year, he was inducted into the Finnish Academy of Science and Letters and awarded the Federation of Finnish Learned Societies Gold Medal. Other notable accolades include the George Winter Award by the European Society for Biomaterials in 2021 and the Doctor of Odontology Honoris Causa from the University of Eastern Finland in 2022. These honors reflect his significant impact on dental research and practice.

📚Top Noted  Publications

Professor Vallittu’s scholarly work is extensive, with over 740 peer-reviewed publications. His recent articles include:

1. Effect of Different Surface Treatments on Shear Bond Strength of Autopolymerizing Repair Resin to Denture Base Materials Processed with Different Technologies

  • Journal: Journal of Prosthodontic Research

  • DOI: 10.2186/jpr.JPR_D_23_00149

  • Summary: This study evaluated the impact of chemical, mechanical, and combined surface treatments on the shear bond strength (SBS) between autopolymerizing repair resins and various denture base materials, including heat-cured, CAD-CAM milled, and 3D-printed resins. Results indicated that surface treatments significantly influenced SBS, with air particle abrasion and 180-grit abrasive paper enhancing bond strength, particularly for 3D-printed materials. jstage.jst.go.jp+1jstage.jst.go.jp+1jstage.jst.go.jp+2pubmed.ncbi.nlm.nih.gov+2jstage.jst.go.jp+2

2. Impact of Restorative Material on Fracture Behaviors of Class II Restoration in Endodontically Treated Deciduous Molars

3. Clinical Evaluation of Posterior Flowable Short Fiber-Reinforced Composite Restorations Without Proximal Surface Coverage

  • Journal: Odontology

  • DOI: 10.1007/s10266-024-00905-5

  • Summary: This randomized clinical trial assessed the performance of posterior restorations using flowable SFRC without proximal surface coverage. Over an 18-month period, the restorations demonstrated satisfactory clinical outcomes, with no significant differences in marginal integrity or color match between the intervention and control groups. link.springer.compubmed.ncbi.nlm.nih.gov

4. Biomechanical Considerations of Semi-Anatomic Glass Fiber-Reinforced Composite Implant for Mandibular Segmental Defects

  • Journal: Journal of the Mechanical Behavior of Biomedical Materials

  • Summary: This study explored the biomechanical properties of semi-anatomic glass fiber-reinforced composite implants used in mandibular segmental defect reconstructions. The findings highlighted the material’s potential in providing adequate mechanical support and promoting osseointegration, offering a promising alternative to traditional metal implants.

5. Co-Influence of Restoration Bonding and Inlay Cavity Design on Fracture Load of Restored Tooth

  • Journal: European Journal of Prosthodontics and Restorative Dentistry

  • DOI: 10.2186/jpr.JPR_D_23_00149

  • Summary: This study investigated how inlay cavity design (edge-shaped vs. round) and bonding quality affect the fracture load of restored teeth. Results indicated that bonding quality significantly influenced fracture resistance, with round-shaped cavities bonded with high-quality protocols exhibiting the highest fracture loads.

Conclusion

Professor Pekka K. Vallittu’s career exemplifies the highest standards of scientific excellence, innovation, leadership, and societal impact in biomaterials science and prosthodontics. His extensive research output, successful translation of inventions to clinical practice, leadership in academia and industry, and broad recognition by prestigious awards strongly position him as an outstanding candidate for the Research for Distinguished Scientist Award.

Dr YUKSEL ÇETİN | Functional Biomaterials | Best Researcher Award

Dr YUKSEL ÇETİN | Functional Biomaterials | Best Researcher Award 🏆

Chief Researcher at The Scientific and Technological Research Council (TUBITAK), Marmara Research Center (MAM)🎓

Dr. Yüksel Çetin is the Chief Researcher at the Life Sciences, Medical Biotechnology Unit of TUBITAK’s Marmara Research Centre, Turkey. He earned his PhD in Food Science and Technology from the University of Nebraska-Lincoln, with a minor in Toxicology. His postdoctoral work focused on pulmonary disease pathogenesis through the FP 6 PULMONET project. Yüksel specializes in in vivo and in vitro toxicology, studying novel drugs, biomaterials, and nanoparticles. He leads several funded projects, including NANOBIO4CAN for cancer therapies and the development of 3D cardiac patches. His commitment to innovation and safety in biotechnology highlights his significant contributions to the field.

 

Professional Profile 

Education 🎓

Yüksel Çetin earned his PhD in Food Science and Technology from the University of Nebraska-Lincoln, USA, with a minor in Toxicology from the Toxicology Centre for Environmental Toxicology at the Eppley Institute for Research in Cancer and Allied Diseases. His postdoctoral research focused on the pathogenesis of pulmonary disease through the FP 6 PULMONET Marie Curie Project at the European Commission’s Joint Research Centre.

Work Experience 🏢

Currently serving as Chief Researcher at the Life Sciences, Medical Biotechnology Unit of the Scientific & Technological Research Council of Turkey (TUBITAK) at the Marmara Research Centre, Yüksel has held multiple leadership roles in various research projects, overseeing significant budgets and collaborative efforts aimed at advancing medical biotechnology and toxicology.

Skills 🔬

Yüksel possesses extensive expertise in in vivo and in vitro toxicology, molecular mechanisms of drugs, biomaterials, and medical devices. His proficiency in three-dimensional bioprinting technology and nanoparticle research is complemented by a robust background in evaluating the pathogenicity of xenobiotics.

Awards and Honors 🏆

He has been recognized for his innovative contributions to medical biotechnology and has received multiple grants and funding for his research projects, underlining his reputation as a leader in the field.

Membership 🌍

Yüksel is an active member of various scientific organizations and advisory boards, including involvement in Horizon 2020 projects focused on nanotechnology and safety assessments, emphasizing his commitment to advancing scientific research and innovation.

Teaching Experience 👨‍🏫

With a wealth of knowledge, Yüksel has shared his expertise through teaching roles at various academic institutions, focusing on topics related to food science, toxicology, and medical biotechnology, mentoring the next generation of scientists.

Research Focus 🔍

His research primarily investigates the toxicological effects of novel drugs, biomaterials, and nanoparticles, as well as the development of innovative therapeutic approaches for cancer treatment. Yüksel’s projects encompass antiviral research, tissue regeneration, and vaccine development, demonstrating his dedication to impactful scientific advancements.

 

Publications : 

  • Cytotoxicity of Fusarium mycotoxins to mammalian cell cultures as determined by the MTT bioassay
    Year: 2005
    Journal: Food and Chemical Toxicology
  • In vitro evaluation of the toxicity induced by nickel soluble and particulate forms in human airway epithelial cells
    Year: 2011
    Journal: Toxicology in vitro
  • Evaluation of reduced toxicity of zearalenone by extrusion processing as measured by the MTT cell proliferation assay
    Year: 2005
    Journal: Journal of Agricultural and Food Chemistry
  • Characterisation of cadmium chloride induced molecular and functional alterations in airway epithelial cells
    Year: 2009
    Journal: Cellular Physiology and Biochemistry
  • Evaluation of the molecular mechanisms of a palladium (II) saccharinate complex with terpyridine as an anticancer agent
    Year: 2014
    Journal: Anti-Cancer Drugs
  • A novel system to study the impact of epithelial barriers on cellular metabolism
    Year: 2000
    Journal: Annals of Biomedical Engineering
  • Confirmation of reduced toxicity of deoxynivalenol in extrusion-processed corn grits by the MTT bioassay
    Year: 2006
    Journal: Journal of Agricultural and Food Chemistry
  • The neutralization effect of montelukast on SARS-CoV-2 is shown by multiscale in silico simulations and combined in vitro studies
    Year: 2022
    Journal: Molecular Therapy
  • The Development of Novel Approaches to the Identification of Chemical and Protein Respiratory Allergens: Progress made from the Conclusions and Recommendations of ECVAM Workshop 60
    Year: 2008
    Journal: Alternatives to Laboratory Animals
  • Fabrication of a dual-drug-loaded smart niosome-g-chitosan polymeric platform for lung cancer treatment
    Year: 2023
    Journal: Polymers
  • Instant determination of the artemisinin from various Artemisia annua L. extracts by LC‐ESI‐MS/MS and their in‐silico modelling and in vitro antiviral activity
    Year: 2022
    Journal: Phytochemical Analysis
  • A palladium (II)–saccharinate complex of terpyridine exerts higher anticancer potency and less toxicity than cisplatin in a mouse allograft model
    Year: 2017
    Journal: Anti-Cancer Drugs